Health
Veiny, Wrinkled Hands? Shave Off Years With These Non-Invasive Tricks
Palms are very important instruments. We use them for for speaking and comforting, in addition to cooking, cleansing, scrubbing, washing, gardening, and all the different chores on our to-do lists. Over the course of a lifetime, our fingers actually take a beating. This, mixed with the truth that the pores and skin on our fingers is pretty skinny, is why they have an inclination to indicate indicators of ageing earlier than different elements of our physique — and one of many clearest indicators of ageing in fingers is bulging, distinguished veins.
Getting old is each a present and a badge of honor. It’s proof you’ve lived. But when veiny fingers are one thing you’d reasonably not take care of, excellent news: There are strategies to make the veins in your fingers much less obvious. Hold studying to be taught extra about how one can shave years off your mitts.
Why do our fingers get veiny as we age?
Consider two separate fingers: One of a kid, and one in all an older particular person. What is among the most noticeable variations between the 2? Chances are high, the older hand you pictured has bulging, seen veins all all through the again — however why is that? It’s not that our veins get bigger — however reasonably that our pores and skin really thins as we age, says the Vein Institute, which makes our veins extra obvious. Different pure elements of the ageing course of, like adjustments in pores and skin elasticity and blood stress, could make them extra seen as effectively. Like thinning hair and tremendous traces, veiny fingers are an inevitable a part of ageing that many would favor to keep away from, however they aren’t sometimes trigger for medical concern.
How To Make Veiny Palms Smoother
If hand veins make you self-conscious, you aren’t alone. Veiny fingers aren’t unsuitable or dangerous, however if you wish to smoothen their look, there are a number of avenues you may take. Sadly, the one assured strategy to do away with veiny fingers is thru surgical procedures. One of the fashionable vein-minimizing surgical procedures is sclerotherapy, a course of wherein liquid foam is injected straight into veins, inflicting them to vanish. For those who’re not thinking about getting surgical procedure, although, listed here are some simple, non-invasive at-home ideas which will make your hand veins much less distinguished.
Keep hydrated.
Dehydration could make ageing on pores and skin and fingers extra apparent, say the sweetness execs at Be Vivid You. The kicker? Our thirst sensations diminish as we age, too, making older adults extra prone to be dehydrated than their youthful counterparts. One strategy to inform in case you’re dehydrated is to do the pinch check. Pinch the pores and skin on the again of your hand, and if it doesn’t bounce again rapidly, chances are you’ll be in want of hydration. Sip a cup or two of water to get your liquid ranges the place they should be.
Hold moisturized.
Routine use of a moisturizing lotion won’t solely make your pores and skin softer, however it should additionally assist visually shrink your veins. Utilizing lotion aids in moisture retention, which retains pores and skin plump and agency, doubtlessly making veins look smaller, based on Be Vivid You. With so many hydrating lotions available on the market, it may be exhausting to decide on one. Why not strive one from Dolly Parton’s favourite model, Olay (Purchase from Walmart.com, $5.97)? If it’s ok for Dolly, it’s ok for us.
Do hand stretches.
Common hand and wrist stretches can enhance flood movement, which can scale back the looks of huge hand veins, says The Kimmel Institute. To strive it: Press your palms collectively and lift elbows up and away out of your physique. As soon as you’re feeling rigidity in your interior wrist, drop wrists to your abdomen.
Will you strive these methods for smoothing out veiny fingers? When you’re at it, try different methods to look youthful, like face yoga, or be taught to embrace your ageing physique with ideas from a gray-haired mannequin.
Girl’s World goals to characteristic solely the perfect services. We replace when doable, however offers expire and costs can change. For those who purchase one thing by way of one in all our hyperlinks, we might earn a fee.
Questions? Attain us at store@womansworld.com.
Health
Going to bed after this time could lead to poorer mental health, a Stanford study finds
Night owls might want to start turning in earlier.
A recent study by Stanford University, published in the journal Psychiatry Research, found that going to bed after 1:00 a.m. could lead to mental health issues.
Researchers analyzed the data of more than 73,000 adults in the U.K., looking into their chronotype (inclination to rise early or stay up late) and actual sleep timing.
FEELING HUNGRIER THAN USUAL? YOUR SLEEP SCHEDULE COULD BE THE CULPRIT, AN EXPERT SAYS
The study then examined the alignment between the two and the prevalence of mental, behavioral and neurodevelopmental disorders (MBN), as well as depression and anxiety.
People with a morning preference who go to bed early exhibit “better mental health” compared to morning types who go to bed late, the study found.
Morning types who tend to go to bed late have an increased risk of MBNs, depression and anxiety.
People with an evening preference who sleep late were also found to demonstrate poorer mental health. Evening types who wake up early, conversely, have a lower risk of developing depression.
Based on these findings, the researchers recommended going to sleep before 1:00 a.m., regardless of preference.
AMERICANS NEED MORE SLEEP, LESS STRESS, EXPERTS SAY, AS GALLUP POLL REVEALS TROUBLING FINDINGS
Study co-author Jamie Zeitzer, Ph.D., a professor at Stanford University’s department of psychiatry and behavioral sciences in California, said he was surprised by the results.
“They were not what we expected at all,” he wrote in an email to Fox News Digital. “We spent more than a year trying to disprove our findings, but could not find an alternate explanation.”
The researchers originally anticipated that individuals who aligned their actual sleep timing with their morning/evening preference would have the best mental health, Zeitzer noted – but this was not the case.
“Rather, we found that being awake late at night, irrespective of preferred sleep timing, was associated with worse mental health,” he said.
Good sleep is “crucial for establishing a pillar of good mental health,” according to Zeitzer.
TYPE 2 DIABETES A MUCH GREATER RISK FOR ‘NIGHT OWLS’ THAN FOR EARLY BIRDS, A ‘STARTLING’ NEW STUDY FINDS
“It is not necessarily [the case] that bad sleep causes poor mental health, but it can definitely facilitate poorer mental health,” he said.
“There are several aspects of sleep that contribute [to mental health], including the duration (which we accounted for in our study) and the timing (which we directly examined in our study).”
While it might not be detrimental for all night owls to stick to their preferred nighttime sleep schedule, Zeitzer said, the research highlights that it presents a risk for some.
“We are not clear as to why this is the case, but it may have to do with the isolation that often accompanies such late-night behavior,” he said.
“So, being aware of how you are spending your late nights and whether these behaviors are conducive to good mental health is crucial.”
WANT TO BE A MORNING PERSON? THESE 6 EXPERT TIPS MAY GET YOU THERE
Dr. Wendy Troxel, a Utah-based sleep expert who was not involved in the study, agreed that the findings are “very interesting” – particularly the fact that going to bed later is associated with poorer mental health regardless of one’s natural tendency.
“These findings underscore that sleep health is a multidimensional state,” Troxel said in an interview with Fox News Digital.
“It’s not just about getting enough sleep or good quality sleep that matters, but the timing matters, too.”
“Going to bed excessively late on a regular basis may lead to impairments in decision-making and emotion regulation.”
Failing to get enough sleep has been proven to compromise mental health by “influencing brain mechanisms that help to regulate emotions,” she added.
“Going to bed excessively late (i.e., after 1 a.m.) on a regular basis may lead to impairments in decision-making and emotion regulation, which may underlie associations with mental health problems, such as depression and anxiety,” she said.
The study results are also interesting when applied to specific groups who tend to be night owls, like teenagers, Troxel noted.
“Biologically, teenagers are predisposed to stay awake later and sleep in later, which is in conflict with early school start times,” she said.
“This can set them up for a ‘double whammy’ of both insufficient sleep and delayed sleep schedules, which can contribute to mental health problems — a major public health issue among teenagers.”
3 critical steps for better sleep
Troxel recommends taking the following steps to improve the quality of sleep.
First, slowly advance bedtime earlier by 15-minute increments each week.
Next, allow for plenty of sunlight in the morning, she advised, as sunlight is “one of the most powerful cues to help set the circadian rhythm.” In the evening, keep the lights low.
For more Health articles, visit foxnews.com/health.
Finally, stay consistent with your sleep schedule, including on weekends, Troxel suggested.
While this can be challenging, especially for night owls, reverting to a later bedtime and wake-up times will “set you back to square one,” she warned.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The key to successfully shifting sleep habits is to do it gradually, Troxel said.
“It’s similar to the approach we would recommend for changing one’s schedule to manage jetlag,” she said.
Zeitzer noted that it can be difficult for anyone to switch up their sleep schedules, especially for those who prefer more “extreme times,” like staying up until 4:00 a.m. or waking up before 5:00 a.m.
Going to bed and waking up at the same time every day is the best way to successfully make a shift, he said, along with exposure to bright light.
Health
AI blood test could detect Parkinson's disease up to 7 years before symptoms: 'Particularly promising'
A new blood test could reveal Parkinson’s diagnoses up to seven years before symptoms emerge.
Researchers from University College London and University Medical Center Goettingen in Germany used artificial intelligence to develop the test.
The study, which was published in the journal Nature Communications, included 72 patients with rapid eye movement behavior disorder (iRBD), a condition that has been linked to a higher risk of Alzheimer’s.
WHAT IS ARTIFICIAL INTELLIGENCE?
When the researchers used machine learning to analyze blood samples from the patients, they discovered that 79% of them had the same biomarkers as people with Parkinson’s.
Over a 10-year follow-up period, the researchers confirmed that 16 of the patients went on to develop Parkinson’s, a movement disorder that affects nearly one million people in the U.S.
“By determining eight proteins in the blood, we can identify potential Parkinson’s patients several years in advance,” said co-first-author Dr. Michael Bartl from the University Medical Center Goettingen in a press release.
MILITARY VETERAN EMBRACES ‘NEW SERVICE’ OF HELPING OTHERS AFTER HIS PARKINSON’S DIAGNOSIS: ‘THERE IS HOPE’
“This means that drug therapies could potentially be given at an earlier stage, which could possibly slow down disease progression or even prevent it from occurring.”
“We have not only developed a test, but can diagnose the disease based on markers that are directly linked to processes such as inflammation and degradation of non-functional proteins. So these markers represent possible targets for new drug treatments.”
Blood tests provide a less invasive alternative to a lumbar puncture (also known as a spinal tap), which has been used more often to diagnose Parkinson’s in clinical research, according to professor David Dexter, director of research at Parkinson’s UK.
“This research, co-funded by Parkinson’s UK, represents a major step forward in the search for a definitive and patient friendly diagnostic test for Parkinson’s,” Dexter said in the release.
RESEARCHERS FIND SOURCES OF FOUR BRAIN DISORDERS, WHICH COULD LEAD TO NEW TREATMENTS
Looking ahead, the researchers plan to follow the participants to confirm the accuracy of the test, and will also analyze samples from others in the population who have a genetic mutation that puts them at a higher risk of developing Parkinson’s.
“The findings add to an exciting flurry of recent activity toward finding a simple way to test for and measure Parkinson’s.”
“With more work, it may be possible that this blood-based test could distinguish between Parkinson’s and other conditions that have some early similarities, such as multiple systems atrophy or Lewy body dementia,” Dexter said in the release.
“The findings add to an exciting flurry of recent activity toward finding a simple way to test for and measure Parkinson’s.”
Dr. Harvey Castro, a Dallas, Texas-based board-certified emergency medicine physician and national speaker on AI in health care, was not involved in the blood test but spoke to Fox News Digital about its potential impact.
For more Health articles, visit www.foxnews/health.
“As an ER physician deeply involved in AI applications in health care, I find this development particularly promising,” Castro said.
“It exemplifies the potential of AI to diagnose and predict serious health conditions, allowing for earlier and potentially more effective interventions.”
This approach could serve as a model for other diseases, Castro suggested.
“Having a tool that provides more time before significant nerve cell damage occurs offers a substantial opportunity to address diseases at very early stages, where traditional diagnostic methods might not detect them,” the doctor said.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“This early intervention capability could significantly slow the disease progression.”
Although knowing about a disease in advance can help patients prepare mentally and emotionally, Castro warned that it could be a “double-edged sword.”
“While some patients may benefit from early knowledge and the ability to plan their lives accordingly, others might prefer not to know about a potential future illness due to the psychological burden it could impose,” he said.
Overall, Castro said, this AI-powered blood test represents a “paradigm shift” in the approach to neurodegenerative diseases like Parkinson’s.
“It underscores the importance of integrating advanced technologies into medical practice to enhance patient outcomes and transform health care delivery,” he said.
Fox News Digital reached out to the study researchers for additional comment.
Health
FDA approves new drug to treat autoimmune liver disease: ‘Giant step forward’
A new drug to control liver disease has gotten the green light.
The U.S. Food and Drug Administration (FDA) has approved the French drugmaker Ipsen’s medication Iqirvo (elafibranor).
The drug, an 80 mg tablet administered orally once daily, is intended to treat an autoimmune cholestatic liver disease called primary biliary cholangitis (PBC).
What is PBC?
PBC is a disease in which the immune system attacks and destroys the small bile ducts of the liver.
IN ALZHEIMER’S BREAKTHROUGH, RESEARCHERS IDENTIFY ‘PROTECTIVE GENE’ THAT DELAYS DISEASE IN HIGH-RISK FAMILY
Without the active bile ducts, acids can then leak into the nearby tissue and cause liver damage or failure, according to the National Institutes of Health (NIH).
The disease typically involves chronic inflammation along with a stagnant build-up of bile and toxins known as cholestasis, which can lead to irreversible scarring of the liver and ultimately destroy the bile ducts.
Although PBC is considered a rare condition, it can often go undetected, some health experts said.
“PBC is likely to be way underdiagnosed,” Dr. Douglas Dieterich, M.D., director of the Institute for Liver Medicine at Mount Sinai Health System in New York City, told Fox News Digital.
CAN YOU BECOME DRUNK WITHOUT DRINKING ALCOHOL? HERE’S HOW IT COULD HAPPEN
“Many people — mostly women — have elevated liver enzymes that can be easily diagnosed with a simple blood test called the AMA.”
Patients typically experience severe fatigue and significant itching called pruritus.
If the disease is not treated or an individual does not respond to current therapies, it can lead to liver failure, the need for a liver transplant or even early death, according to experts.
PBC is diagnosed with a blood test that measures liver enzymes.
One common test analyzes the patient’s alkaline phosphatase (ALP), an enzyme that helps detect liver or bone disease.
Another blood test to diagnose PBC measures antimitochondrial antibodies (AMAs), which are positive in approximately 95% of patients with the condition, according to several liver experts.
Patient welcomes more treatment options
One New York patient with PBC told Fox News Digital that she did not know she had a liver disease until her primary care physician performed routine blood work and noticed that her liver enzymes were elevated.
Meredith S., who withheld her last name for privacy reasons, was referred to a hepatologist, whom she credits for saving her life.
“It is distressing to know that your body is fighting itself and you can’t figure out how to stop it.”
“I was feeling tired, but attributed it to working and studying at school,” she told Fox News Digital.
“I was completely surprised to find out I had a liver disease and learned it was PBC.”
She went on, “My doctor performed a liver biopsy and I had significant scarring of my liver in my 30s, even though I didn’t drink alcohol.”
Meredith S. said she is glad there are more treatment options available, and hopes for more awareness and research of PBC.
“It is distressing to know that your body is fighting itself and you can’t figure out how to stop it,” she told Fox News Digital.
Addressing an ‘unmet need’
Dieterich of New York City, who is also a professor of medicine at the Icahn School of Medicine at Mount Sinai, told Fox News Digital that this newly approved medication “is a giant step forward in the treatment of PBC.”
He noted, “This is a giant step forward in the treatment of PBC. Up to now, there has been only one drug available to add to the urso, which is the basis for PBC treatment. Now there are two.”
STUDY DISCOVERS ‘TRIGGER GENE’ IN IBD AS RESEARCHERS LOOK FOR DRUGS TO PREVENT THE BOWEL DISEASE
The existing drug, ursodeoxycholic acid (UDCA) — commonly called ursodial or “urso” — is a naturally occurring bile acid that has been used to treat liver disease for decades.
The newly approved Iqirvo (elafibranor) is intended to be used in combination with UDCA in patients who are not responding to the first medication on its own, or can be used on its own for people who cannot tolerate UDCA.
“For a significant number of people living with PBC, available treatments do not control the condition and may exacerbate symptoms of PBC,” said Christelle Huguet, executive vice president and head of research and development at Ipsen, in a press release.
“Iqirvo demonstrated statistically significant improvements in biochemical response compared to UDCA alone. Iqirvo is therefore a much-needed treatment option and the first new medicine for PBC in nearly a decade.”
Primary biliary cholangitis affects approximately 100,000 people in the U.S.
The accelerated approval for Iqirvo was based on positive results from the Phase III ELATIVE trial, which showed reduced levels of the alkaline phosphatase enzyme, which is elevated in people with liver disease.
The study, published in The New England Journal of Medicine, included 161 patients with PBC who were inadequately responding to treatment with UDCA or could not tolerate that medication.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Researchers found that 51% of the patients who received the elafibranor had a biochemical response, compared to only 4% who received a placebo.
After 52 weeks, the patients who were treated with elafibranor showed normalized liver enzymes, compared to 15% of patients in the placebo group.
“Data from the pivotal Phase III ELATIVE clinical trial demonstrated that Iqirvo is an effective second-line treatment for patients with PBC with favorable benefit and risk data,” Dr. Kris Kowdley, a primary investigator on the ELATIVE study and the director at Liver Institute Northwest, Washington, said in a news release.
“The approval of Iqirvo will allow health care providers in the U.S. to address an unmet need, with the potential to significantly reduce ALP levels for our patients with PBC,” he added.
Continued approval is contingent upon further studies showing improved survival or prevention of liver decomposition, the FDA report noted.
Potential side effects and limitations
Some reported side effects of Iqirvo included muscle pain, rhabdomyolysis, myopathy, fractures, weight gain and drug-induced liver injury, according to the FDA report.
Also noted was the potential risk to the fetus in pregnant patients, based on animal study data.
The FDA cautioned health care providers to ensure that patients are not pregnant prior to starting the medication.
Iqirvo is also not recommended in patients who have advanced stages of cirrhosis.
For more Health articles, visit www.foxnews/health
Primary biliary cholangitis affects some 100,000 people in the United States, according to the drugmaker Ipsen.
It is a lifelong disease that can result in liver failure if left untreated, according to experts.
-
Politics1 week ago
President Biden had front row seat to dog, Commander, repeatedly biting Secret Service agents: report
-
News1 week ago
171,000 Traveled for Abortions Last Year. See Where They Went.
-
Politics1 week ago
Trump travels to DC to meet with congressional Republicans, speak with nation's top business executives
-
World1 week ago
The far right will probably fall short in French legislative elections
-
Politics1 week ago
Durbin looks to force Supreme Court ethics bill vote amid Alito controversy
-
News1 week ago
Photographer shares ‘magical’ photos of rare white bison calf at Yellowstone
-
News6 days ago
It's easy to believe young voters could back Trump at young conservative conference
-
World1 week ago
Hezbollah rains rockets on Israel after senior commander killed